Unlocking new modalities

for prostate cancer patients

 Developing selective, targeted and first-in-class therapies

About Us

Alata

Alice

Open Sans

Noto Sans

Bebas Neue

Great Vibes

Rock Salt

Exo

Belgrano

Overlock

Cinzel

Indie Flower

Staatliches

Roboto Slab

Lato

Noto Serif

Open Sans

Montserrat

Ubuntu

Rubik

Delius

Amiri

Montserrat

small steps towards better health

Selective delivery via PSMA targeting

Harnessing PSMA as a point of entry into prostate cancer cells

Established biological concept

Removing from the cells proteins causing prostate cancer growth

Building tomorrow

Pi-SMA therapeutics is driving the development of new molecules by combining two validated biological concepts

Our technology

Let's accelerate prostate cancer research together

Share by: